Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation von Peres, E, Levine, J E, Khaled, Y A, Ibrahim, R B, Braun, T M, Krijanovski, O I, Mineishi, S, Abidi, M H

Volltext

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease von KRIJANOVSKI, O. I, HILL, G. R, COOKE, K. R, TESHIMA, T, CRAWFORD, J. M, BRINSON, Y. S, FERRARA, J. L. M

Volltext

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL von Peres, E, Braun, T, Krijanovski, O, Khaled, Y, Levine, J E, Yanik, G, Kato, K, Mineishi, S

Volltext

Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline von Peres, E., Khaled, Y., Krijanovski, O.I., Mineishi, S., Levine, J.E., Kaul, D.R., Riddell, J.

Volltext

The β chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor von JUBINSKY, P. T, KRIJANOVSKI, O. I, NATHAN, D. G, TAVERNIER, J, SIEFF, C. A

Volltext

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity von Hill, G R, Teshima, T, Rebel, V I, Krijanovski, O I, Cooke, K R, Brinson, Y S, Ferrara, J L

Volltext

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses von Reddy, Pavan, Maeda, Yoshinobu, Liu, Chen, Krijanovski, Oleg I, Korngold, Robert, Ferrara, James L M

Volltext

Rapid Immunosuppression Taper Following Reduced Intensity HCT From Related Donor Is Tolerable But Does Not Improve Outcomes of Advanced Hematologic Malignancies von Krijanovski, O, Krijanovski, Y, Khaled, Y, Cummings, T, Braun, T, Reddy, P, Peres, E, Mineishi, S, Kitko, C, Choi, S, Yanik, G, Pawarode, A, Paczesny, S, Levine, J.E

Volltext

167: Reduced Intensity Versus Full Myeloablative Stem Cell Transplant for Advanced Chronic Lymphocytic Leukemia von Peres, E, Levine, J, Kato, K, Krijanovski, O, Khaled, Y, Ferrara, J, Yanik, G, Mineishi, S

Volltext

Day7 TNFR1 Levels Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HCT) Predict For Acute GVHD von Kitko, C.L, Mineishi, S, Braun, T, Choi, S.W, Jones, D, Harris, A, Khaled, Y, Krijanovski, O, Paczesny, S, Peres, E, Yanik, G, Whitfield, J, Ferrara, J.L, Levine, J.E

Volltext

Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease von Krijanovski, Oleg I., Hill, Geoffrey R., Cooke, Kenneth R., Teshima, Takanori, Crawford, James M., Brinson, Yani S., Ferrara, James L.M.

Volltext

171: Allogeneic Hematopoietic Stem Cell Transplantation has Curative Potential for Chemorefractory Non-Hodgkin Lymphoma von Kato, K, Krijanovski, O, Khaled, Y, Peres, E, Reddy, P, Choi, S, Kitko, C, Yanik, G, Levine, J, Ferrara, J, Mineishi, S

Volltext

29: Addition of Etanercept to Methylprednisolone as Initial Therapy for Acute GVHD Results in High Response Rates and Improved Survival von Levine, J.E, Paczesny, S, Mineishi, S, Braun, T, Choi, S.W, Hutchinson, R.J, Jones, D, Khaled, Y, Kitko, C.L, Bickley, D, Krijanovski, O, Reddy, P, Yanik, G, Ferrara, J.L.M

Volltext

Elevated TNF receptor levels early after myeloablative BMT predict for GVHD and death von Levine, J.E., Yanik, G.A., Cooke, K.R., Reddy, P., Hutchinson, R., Krijanovski, O., McMahon, C., Whitfield, J., Ferrara, J.L.

Volltext

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL von Peres, E, Braun, T, Krijanovski, O, Khaled, Y, Levine, J.E, Yanik, G, Kato, K, Mineishi, S

Volltext

EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis von Stuart, R O, Pavlova, A, Beier, D, Li, Z, Krijanovski, Y, Nigam, S K

Volltext

EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis von STUART, Robert O, PAVLOVA, Anna, BEIER, David, ZHIXING LI, KRIJANOVSKI, Yelena, NIGAM, Sanjay K

Volltext